Positive VOLGA Phase III Results for Imfinzi Plus Neoadjuvant EV in MIBC
oncodaily - On May 14, 2026, AstraZeneca announced positive high-level results from a planned interim analysis of the Phase III VOLGA trial, evaluating perioperative Imfinzi with or without Imjudo in combination with […]
AI Summary: Phase III VOLGA trial results reveal that combining durvalumab (Imfinzi) with neoadjuvant enfortumab vedotin improved survival outcomes in muscle‑invasive bladder cancer. Investigators and industry voices highlight potential practice-changing implications for perioperative therapy, while stakeholders weigh regulatory filings and integration into treatment guidelines. Clinicians will want full datasets and toxicity details.
- Clinician reactions, biology and resistance concerns (4)
- Global GU oncology meetings and community coverage (3)
- VOLGA Phase III readout and regulatory landscape (3)
- All Other Stories
Clinician reactions, biology and resistance concerns
Global GU oncology meetings and community coverage
VOLGA Phase III readout and regulatory landscape
All Other Stories
Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61
Related Stories
Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128
Datroway secures regulatory approvals in breast cancer across US and EU / 8 days
FDA clears first targeted therapy for ultra-rare NRG1-driven cholangiocarcinoma / 20 days
FDA grants early access to experimental pancreatic cancer drug / 29 days
FDA approves relacorilant plus nab‑paclitaxel for resistant ovarian cancers / 7 wks
FDA flags misleading cancer drug claims tied to biotech billionaire / 2 months
FDA clears pivekimab sunirine (Decnupaz) as first BPDCN ADC / 46 hrs
FDA to revisit Atara/Pierre Fabre cell therapy approval for rare lymphoma / 22 days
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Weight Loss, Animal Health, Biotech, Vaccine Safety and look for the RSS link.
StackHealth Time Machine